Please complete the CAPTCHA to continue
@xomix.com
✓
2 phones found area 773 and 401
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Gary Keller is listed as CEO Xomix Ltd. at Foresight Science & Technology, based in Greater Chicago Area, United States, United States. AeroLeads shows a work email signal at xomix.com, phone signal with area code 773, 401, and a matched LinkedIn profile for Gary Keller.
Gary Keller previously worked as CEO at Xomix Ltd and Chief Business Officer at Regenero & Cells For Cells. Gary Keller holds Certification, Biotechnology: Strategies For Management Of Intellectual Property from Northwestern University - Kellogg School Of Management.
This section adds company-level context without repeating Gary Keller's masked contact details.
AeroLeads found 1 current-domain work email signal for Gary Keller. Compare company email patterns before reaching out.
Gary Keller is founder and CEO of Xomix Ltd., a global technology accelerator and consultancy engaged in intellectual asset management, the commercialization of innovations, technology businesses development and partnering, and the design and implementation on strategic commercialization and technology led economic development initiatives. He is also CEO of Cadeucis BioVentures providing investment into early stage companies. Xomix focuses on the commercialization and intellectual asset management of technologies in biopharma, life sciences, cleantech, and other related area for industry, government, academia, and quasi-government organizations. Keller has served as an expert in the evaluation, strategy development, licensing and commercialization of start-up, emerging, mid-sized, and Fortune 500 companies. Xomix is known for the ability to bring together subject matter experts, key market participants, IP holders, and stakeholders to maximized value.Keller has served in a number of leadership roles that utilize his expertise in the development and launch of new initiatives including the Florida Institute for the Commercialization of Public Research, the BiTmaP Program, Conkwest Inc, and Cell Therapy for Cambrex BioSciences. He has more than 25 years of experience in business development for leading biotechnology companies including corporate development, product development, market development, sales, and scientific research and development. He is known as an international speaker on the topics of marketing genetic therapies, commercialization of technologies, virtual incubation of companies, biotechnology led economic development, technology evaluation, technical sales and marketing development. He has conducted business throughout the U.S. and around the world. Keller has published in scientific journal and industry magazines, as well as co-authoring industry reports in key biotechnology Keller serves on the Board of Directors of Mount Sinai Hospital (Chicago, IL) and numerous advisory boards for scientific organizations.Specialties: Transformational leader in business development, commercialization, and strategic initiatives. Accelerated results in corporate and not-for-profit financial goals, operations, fundraising, and strategic planning. In-depth experience in life science, healthcare, and biotechnology markets.Accomplished in product development, intellectual property management, sales and marketing, and partnering with industry, organization and government entities.
Listed skills include Start Ups, Commercialization, Biotechnology, Business Development, and 45 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Xomix, Ltd. is a global technology accelerator and venture catalyst specializing in commercialization of technologies, corporate development, licensing, and partnerships. Xomix has extensive experience in monetization, strategic planning and initiatives for commercialization and technology startups. We have led economic development in academic.
Cells for Cells and Regenero are Chilean biotechnological companies dedicated to the research, development and commercialization of innovative cellular therapies.
Hopkinton, MA, US
Foresight Science & Technology (Foresight) is one of the leading firms globally in technology transfer support for universities. A 34 year old company, we support between 500 and 800 new technologies each year across all fields of technology and involving almost all sectors of the global economy. The company is headquartered in Providence, RI and has.
Captis Diagnostics is an early stage company with a magnetic nanolipoprobe technology for isolating extracellular vesicles. This role entailed conducting an NIH assessment of the technology leading to executive efforts including business strategy, attraction of venture capital, and establishing collaborative business partnerships.
The Midwest Research University Network (MRUN) - brings regional resources together to foster commercialization and investment across the region and is focused on Midwest Startups. The MRUN Region is bi-national spanning the Midwest portions of Canada and the United States. In the U.S. it includes the states of Illinois, Indiana Iowa, Kansas, Kentucky.
Since iNetworks was founded in 1999, we have helped companies and entrepreneurs accelerate their solutions to combine capital, management, and intellectual resources to solve many of the critical problems affecting the healthcare industry today. The main focus of iNetworks is to provide funding for businesses in the healthcare and life sciences industry.
Lee the restoration and reuse of one of the world's first and last remaining silent film studios as a Center for Early Film and Cultural Performance. Essanay Studios was the center of the early film industry before Hollywood. The Essanay Centers are designed utilize new tools including digital internet and cinematography and sound to create an.
NantKwest Corporation is a biopharmaceutical company whose lead product is a natural killer cell line in Phase I trials as a cancer therapeutic.-Raised $2.3M in Series A financing, $1.4M of seed convertible investment, established a world class scientific advisory board, recruited second-stage management and investment banking support for Series B.
Chicago, IL, US
-Responsible for the leadership, direction and management of new development infrastructure to support growth of the Walter E. Heller College of Business Administration.-Engaged in comprehensive capital campaign including funding for new $110M, 32 story vertical campus to be completed in 2012.-Partnered with corporations, alumni, deans, staff, and faculty.
The Florida Institute for Commercialization of Public Research is a statewide, quasi-governmental, not-for-profit economic development corporation commercializing new discoveries from publicly-funded research.- Provided leadership and direction for new venture creation through commercially-viable technologies in industries including clean energy, life.
Managed the development and operations of the BiTmaP Program, a $6M DOL bioinformatics training program for the Chicago Technology Park with the University of Illinois at Chicago (UIC).-Reallocated assets of a 50,000 s.f. building acquisition -Prepared Economic Impact studies for the Illinois Medical -District and Chicago Technology Park and Research Center.
-Initiated strategic plan and products expansion in the cell therapy market leveraging core manufacturing and regulatory competencies, human cell systems, media products, customer base and market opportunities. -Increased cell therapy market 300% (60% customized products) and international market growth of $2M.-Developed 25 pilot sites for an “On-Site.
-Launched Sanyo products in the U.S. and managed direct and distributed sales for centrifugation, controlled-temperature, and forensic equipment in all laboratory areas within a third of the U.S. -Increased sales over 40% per year to a total of $2.8M.-Launched MSE line of centrifuges including marketing, sales, and technical support for 450 sales reps.
-Managed R&D applications, technical support, and accessory development for solid-phase extraction (SPE).-Developed the SPE drying system, prototype, initial studies, and materials for patent protection.
Quick answers generated from the profile data available on this page.
Gary Keller works for Foresight Science & Technology.
Gary Keller is listed as CEO Xomix Ltd. at Foresight Science & Technology.
AeroLeads has found 1 work email signal at @xomix.com for Gary Keller at Foresight Science & Technology.
AeroLeads has found 2 phone signal(s) with area code 773, 401 for Gary Keller at Foresight Science & Technology.
Gary Keller is based in Greater Chicago Area, United States, United States while working with Foresight Science & Technology.
Gary Keller has worked for Xomix Ltd, Regenero & Cells For Cells, Foresight Science & Technology, Captis Diagnostics Inc., and Midwest Research University Network (Mrun).
You can use AeroLeads to view verified contact signals for Gary Keller at Foresight Science & Technology, including work email, phone, and LinkedIn data when available.
Gary Keller holds Certification, Biotechnology: Strategies For Management Of Intellectual Property from Northwestern University - Kellogg School Of Management.
Gary Keller is listed with skills including Start Ups, Commercialization, Biotechnology, Business Development, Corporate Development, Strategy, Strategic Partnerships, and Fundraising.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts